一种"现成"的CD2全方位CAR-T疗法用于T细胞恶性瘤
Jingyu Xiang1, Jessica M Devenport1, Alun J Carter1
1Division of Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.
Leukemia
|October 5, 2023
概括
针对CD2 (UCART2) 的通用CAR-T细胞在T细胞恶性瘤中表现有前途. 在临床前模型中,将UCART2与互白素-7疗法结合起来可以提高疗效和存活率.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法 细胞疗法
背景情况:
- 由于有限的向治疗,T细胞恶性瘤的预后不佳.
- 化学抗原受体T细胞 (CAR-T) 疗法提供了一个潜在的途径,但在泛T细胞应用中面临挑战.
研究的目的:
- 开发一种针对CD2的全基性,通用CAR-T细胞疗法 (UCART2),在T细胞恶性瘤中具有广泛的疗效.
- 研究CD2表达在CAR-T细胞功能和疗效中的作用.
- 评估UCART2结合复合人间白内素-7融合到Fc片段 (rhIL-7-hyFc) 的治疗潜力.
主要方法:
- 开发UCART2以CD2向,CD2抗原删除和T细胞受体去除,以预防兄弟杀戮和移植对宿主疾病 (GvHD).
- 在T细胞急性淋巴细胞白血病 (T-ALL) 和皮肤T细胞淋巴瘤 (CTCL) 模型中评估UCART2的疗效.
- 用单细胞机密组分析和异种移植模型生成CD19 CAR-T细胞,有或没有CD2删除,用于比较分析.
- 在体内评估UCART2和rhIL-7-hyFc组合疗法在瘤再挑战和患者衍生T-ALL模型中.
主要成果:
- UCART2对T-ALL和CTCL表现出显著的疗效,延长了瘤携带小鼠的存活时间.
- 在CAR-T细胞中的CD2缺失减少了效应细胞因子的产生和抗瘤功效.
- 由于CD2删除而导致的疗效降低,通过与rHIL-7-hyFc.同时使用恢复了.
- 在临床前模型中,rhIL-7-hyFc治疗增强了UCART2持久性和改善了生存率.
结论:
- 异构性,抗兄弟杀伤性UCART2是一种可行的策略,用于治疗T细胞恶性瘤.
- 将UCART2与rhIL-7-hyFc结合起来是一个有前途的治疗方法,可以克服局限性并改善T细胞恶性瘤的结果.
相关概念视频
Tumor Immunotherapy
544
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
544
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


